Alyeska Investment Group »

Nektar Therapeutics shares owned by Alyeska Investment Group

Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by Alyeska Investment Group from 13F filings

Historical chart of Alyeska Investment Group investment in Nektar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nektar Therapeutics held by Alyeska Investment Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nektar Therapeutics by Alyeska Investment Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.0M 3.5M 0.57
2023-09-30 $793k 1.3M 0.60
2011-03-31 $238k 25k 9.47

More positions owned by Alyeska Investment Group

Meta Platforms Cl A (META)
Aercap Holdings Nv SHS (AER)
Take-Two Interactive Software (TTWO)
Epam Systems (EPAM)
Dollar General (DG)
Paycom Software (PAYC)
Twilio Cl A (TWLO)
Burlington Stores (BURL)
Lauder Estee Cos Cl A (EL)
Adobe Systems Incorporated (ADBE)
Oracle Corporation (ORCL)
Autodesk (ADSK)
Xylem (XYL)
Ulta Salon, Cosmetics & Fragrance (ULTA)
Amazon (AMZN)

View all positions for Alyeska Investment Group

Top funds holding Nektar Therapeutics

Vanguard Group
PRIMECAP Management Company
Monaco Asset Management SAM
Citadel Advisors
D. E. Shaw & Co
Alyeska Investment Group
Jacobs Levy Equity Management
Two Sigma Advisers
Marshall Wace
Tang Capital Management
Two Sigma Investments
GSA Capital Partners
Lynx1 Capital Management
Assenagon Asset Management
Millennium Management

View all funds holding Nektar Therapeutics